Xenon制药
41.38
+0.99
+2.45%
XENE
02-06 16:00:00(美东时间)
高
41.74
开
41.09
量
61.14万股
总市值
31.98亿
低
40.80
换
0.79%
额
2527.47万
市盈TTM
亏损
分时
5日
日K
周K
月K
季K
年K
MA
BOLL
成交量
MACD
KDJ
RSI
WR
BIAS
CCI
PSY
讨论
资讯
公告
资料
财务
相关
成分股
Xenon制药(XENE)
01-10 08:05
$Xenon制药(XENE)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-009238 Size: 7 KB
网页链接
Xenon制药(XENE)
01-10 07:55
$Xenon制药(XENE)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-009232 Size: 7 KB
网页链接
Xenon制药(XENE)
01-10 07:55
$Xenon制药(XENE)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-009235 Size: 7 KB
网页链接
Xenon制药(XENE)
01-10 07:55
$Xenon制药(XENE)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-009230 Size: 7 KB
网页链接
Xenon制药(XENE)
01-03 07:55
$Xenon制药(XENE)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-001172 Size: 11 KB
网页链接
Xenon制药(XENE)
01-03 07:55
$Xenon制药(XENE)$
144 Report of proposed sale of securities Accession Number: 0001193125-26-001168 Act: 33 Size: 6 KB
网页链接
Xenon制药(XENE)
2025-12-10 08:45
$Xenon制药(XENE)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-313147 Size: 10 KB
网页链接
Xenon制药(XENE)
2025-12-09 06:15
$Xenon制药(XENE)$
144 Report of proposed sale of securities Accession Number: 0001193125-25-311409 Act: 33 Size: 7 KB
网页链接
Xenon制药(XENE)
2025-12-06 06:55
$Xenon制药(XENE)$
144 Report of proposed sale of securities Accession Number: 0001193125-25-310009 Act: 33 Size: 5 KB
网页链接
Xenon制药(XENE)
2025-12-04 09:25
$Xenon制药(XENE)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-307211 Size: 5 KB
网页链接
Xenon制药(XENE)
2025-12-02 08:45
$Xenon制药(XENE)$
144 Report of proposed sale of securities Accession Number: 0001193125-25-304226 Act: 33 Size: 5 KB
网页链接
Xenon制药(XENE)
2025-12-02 05:15
$Xenon制药(XENE)$
8-K Current report, items 5.02 and 9.01 Accession Number: 0001193125-25-303862 Act: 34 Size: 741 KB
网页链接
Xenon制药(XENE)
2025-12-02 05:15
$Xenon制药(XENE)$
S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-25-303888 Act: 33 Size: 457 KB
网页链接
Xenon制药(XENE)
2025-11-14 23:35
$Xenon制药(XENE)$
SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001274173-25-000274 Act: 34 Size: 9 KB
网页链接
Xenon制药(XENE)
2025-11-04 05:35
$Xenon制药(XENE)$
10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001193125-25-262646 Act: 34 Size: 9 MB
网页链接
Xenon制药(XENE)
2025-11-04 05:05
$Xenon制药(XENE)$
8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001193125-25-262519 Act: 34 Size: 438 KB
网页链接
Xenon制药(XENE)
2025-10-18 06:45
$Xenon制药(XENE)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-242700 Size: 7 KB
网页链接
Xenon制药(XENE)
2025-10-18 06:45
$Xenon制药(XENE)$
3 Initial statement of beneficial ownership of securities Accession Number: 0001193125-25-242698 Size: 15 KB
网页链接
Xenon制药(XENE)
2025-10-18 04:45
$Xenon制药(XENE)$
8-K/A [Amend] Current report, items 5.02, 8.01, and 9.01 Accession Number: 0001193125-25-242583 Act: 34 Size: 1 MB
网页链接
Xenon制药(XENE)
2025-10-17 05:25
$Xenon制药(XENE)$
8-K Current report, item 5.02 Accession Number: 0001193125-25-241546 Act: 34 Size: 1 MB
网页链接